The objective of the present study was to evaluate the relationship between body weight (BW) and hip width (HW) in dairy buffaloes (Bubalus bubalis). HW was measured in 215 Murrah buffaloes with a BW of 341 ± 161.6 kg, aged between three months and five years, and raised in southeastern Mexico. Linear and non-linear regressions were used to construct the prediction models. The goodness of fit of the models was evaluated using the Akaike information criterion (AIC), Bayesian information criterion (BIC), coefficient of determination (R2), mean squared error (MSE), and root MSE (RMSE). Additionally, the developed models were evaluated through internal and external cross-validation (k-folds) using independent data. The ability of the fitted models to predict the observed values was assessed based on the root mean square error of prediction (RMSEP), R2, and mean absolute error (MAE). The relationship between BW and HW showed a high correlation coefficient (r = 0.96, P < 0.001). The chosen fitted model to predict BW was: −176.33 (± 40.83***) + 8.74 (± 1.79***) × HW + 0.04 (± 0.01*) × HW2, because it presented the lowest MSE, RMSE, and AIC values, which were 1228.64, 35.05 and 1532.41, respectively. Therefore, with reasonable accuracy, the quadratic model using hip width may be suitable for predicting body weight in buffaloes.

The aim of the present study was to report canid attacks on sea turtles in northeastern Brazil. The study was conducted on the Sergipe-Alagoas Basin coastline between March 2010 and October 2019. Injured-stranded sea turtles or carcasses were recorded through systematic beach monitoring. The specimens were submitted for clinical or postmortem assessments, providing evidence for the identification of injuries caused by canids. In the study period, 9841 stranded sea turtles were recorded, with the diagnosis of canid attacks in 55 (0.55%) events. Lepidochelys olivacea was the species with the largest number of events (90.90%), followed by Chelonia mydas (7.27%), and Caretta caretta (1.81%). The attacked sea turtles were clinically healthy, with a good body score and no apparent diseases; most were in the reproductive stage. The injuries were mainly found on the front flippers, with considerable loss of musculature affecting the brachial plexus, with the rupture of large blood vessels, and in some cases, exposure of the humerus or oesophagus. Thus, these events hampered the reproductive cycle, limiting the egg-laying process and preventing the hatching of hundreds of new turtles. Therefore, mitigating measures should be implemented, addressing the consequences of abandoning pets and their unsupervised presence on beaches.

Toxoplasma gondii has at least 318 genotypes distributed worldwide, and tropical regions usually have greater genetic diversity. Campeche is a state located in the southeastern region of México and has favourable climate conditions for the replication and dissemination of this protozoan, similar to those in South American countries where broad genetic diversity has been described. Thus, in this study, 4 T. gondii isolates were obtained from tissues of stray dogs and free-range chickens in Campeche, México, and were genotyped by Mn-PCR-RFLP with 10 typing markers (SAG1, altSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) and 5 virulence markers (CS3, ROP16, ROP17, ROP18 and ROP5) to provide new information about the distribution and virulence prediction of T. gondii genotypes. Two isolates of T. gondii genotype #116 and 2 of genotype #38 were obtained from stray dogs and chickens, respectively. The parasite load found in these species was between <50 and more than 35 000 tachyzoites per mg of tissue. Virulence marker genotyping revealed a recombinant 1&3 ROP5 RFLP pattern in 2 ToxoDB #116 isolates with no prediction of virulence in a murine model, while in the 2 ToxoDB #38 isolates, the ROP18/ROP5 combination predicted high virulence. Considering all the typed markers, there is a predominance of type I and III alleles, as constantly reported for the isolates characterized in various regions of México. It is crucial to determine their phenotype to corroborate the genetic virulence profile of the T. gondii isolates obtained in this study.

This paper presents new excavation data on the Chinchihuapi I (CH-I) locality within the Monte Verde site complex, located along Chinchihuapi Creek in the cool, temperate Valdivian rain forest of south-central Chile. The 2017 and 2018 archaeological excavations carried out in this open-air locality reveal further that CH-I is an intermittently occupied site dating from the Early Holocene (~10,000 cal yr BP) to the late Pleistocene (at least ~14,500 cal yr BP) and probably earlier. A new series of radiocarbon dates refines the chronology of human use of the site during this period. In this paper, we describe the archaeological and stratigraphic contexts of the recent excavations and analyze the recovered artifact assemblages. A fragmented Monte Verde II point type on an exotic quartz newly recovered from excavations at CH-I indicates that this biface design existed in at least two areas of the wider site complex ~14,500 cal yr BP. In addition, associated with the early Holocene component at CH-I are later Paijan-like points recovered with lithic tools and debris and other materials. We discuss the geographic distribution of diagnostic artifacts from the site and their probable relationship to other early sites in South America.

Objectives: Health technology financing is often based on randomized controlled trials (RCTs), which are often the same ones used for licensing. Because they are designed to show the best possible results, typically Phase III studies are conducted under ideal and highly controlled conditions. Consequently, it is not surprising that technologies do not always perform in real life in the same way as controlled conditions. Because financing (and price paid) decisions can be made with overestimated results, health authorities need to ask whether health systems achieve the results they expect when they choose to pay for a technology. The optimal way to answer this question is to assess the performance of financed technologies in real-world settings. Health technology performance assessment (HTpA) refers to the systematic evaluation of the properties, effects, and/or impact of a health intervention or health technology in the real world to provide information for investment/disinvestment decisions and clinical guideline updates. The objective is to describe the development and principal aspects of the Guideline for HTpA commissioned by the Brazilian Ministry of Health.

Methods: Our methods used include extensive literature review, refinement with experts across countries, and public consultation.

Results: A comprehensive guideline was developed, which has been adopted by the Brazilian government.

Conclusion: We believe the guideline, with its particular focus on disinvestment, along with the creation of a specific program for HTpA, will allow the institutionalization and continuous improvement of the scientific methods to use real-world evidence to optimize available resources not only in Brazil but across countries.